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Stem cells are fundamental to the development of any tissue or organism via their ability to self-renew, which is aided by 
their unlimited proliferative capacity and their ability to produce fully differentiated offspring, often from multiple 
lineages. Stems cells are long lived and have the potential to accumulate mutations, including in response to radiation 
exposure. It is thought that stem cells have the potential to be induced into a cancer stem cell phenotype and that these 
may play an important role in resistance to radiotherapy. For radiation-induced carcinogenesis, the role of targeted and 
non-targeted effects is unclear with tissue or origin being important. Studies of genomic instability and bystander 
responses have shown consistent effects in haematopoietic models. Several models of radiation have predicted that stem 
cells play an important role in tumour initiation and that bystander responses could play a role in proliferation and self-
renewal. 
STEM CELLS 
The human body originates from a single cell that 
replicates into around 3.72 x 1013 cells (1). In addition to 
this cells are constantly needed to replace those lost, 
while also maintaining the proper stratification of 
organs. Stem cells allow this to be achieved. They 
possess two key features intrinsic to their role; the first 
is their ability to self-renew, which is aided by their 
unlimited proliferative capacity and the second is their 
ability to produce fully differentiated offspring, often 
from multiple lineages(2)  (see figure 1).  
   Stem cells can be categorised either by their potency 
(differential capabilities), or at which stage of 
development development they are derived, although 
these are linked. For example, early embryonic stem 
cells (ESC) derived from the zygote are totipotent and 
are able to differentiate into any cell required for the 
development of a whole organism (3).  In comparison, 
ESCs derived from the inner mass of the blastocyst (3) 
are able to differentiate into all 3 germ layers of the 
embryo (ectoderm, mesoderm, endoderm (2)), but are 
unable to form placental cells (which are derived from 
the trophoblast- the outer cell mass of the blastocyst 
(4)), and as such are termed pluripotent (3). Foetal and 
adult stem cells are either multipotent (capable of 
multiple differentiated progeny) or unipotent (giving 
rise to only one type of differentiated progeny). 
Traditionally both foetal and adult stem cells are 
thought to have differential capabilities limited to the 
tissue they reside in (5).  
The conventional view of stem cell differentiation can 
be seen as a hierarchy, with the stem cells at the top, 
followed by progenitor cells (committed to 
differentiation with finite proliferative capacity), then 
transit amplifying cells, and finally differentiated 
cells(6) . Adult stem cells are usually slowly 
proliferating as the number of progeny is expanded in 
the progenitor and transit amplifying divisions (7).  
Stem cells can show considerable plasticity, with some 
cells capable of giving rise to unexpected progeny e.g. 
adipose stem cells producing osteocytes (although it is 
not yet clear whether this occurs in vivo). Another 
challenge to a traditionalist view are satellite cells.  
Previously categorised as progenitor cells, a fraction of 
their population have been shown to exhibit stem like 
properties and replenish the population of satellite cells 
upon division(8). It has also been recently reported that 
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Figure 1. Schematic representation of stem cell self-renewal 
by symmetric division and provision of progenitor cells by 
asymmetrical division that ultimately differentiate to yield the 
mature cells that make the bulk of the tissue. 
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epithelial cells can de-differentiate back to stem cells in 
vivo (9). A summary of stem cells, their location and 
progeny can be found in Table 1
 
Table 1. Main types of stem cells and lineages of their progeny.
Type  Location Potency Differentiated Progeny 
Early Embryonic Stem Cells(3, 10)   Zygote Totipotent All cells 
Embryonic Stem Cells (ESC)(3, 11)  Inner cell mass of Blastocyst Pluripotent All 3 germ layers of an 
embryo 
Mesenchymal Stem Cells(12-15)  Bone Marrow, teeth, peripheral 
blood and blood from umbilical 
cord, breast tissue 
Multipotent Tenocyte, osteocyte, 
myocyte, adipocyte, 
chrondrocyte, endothelial 
cells.  
Haemapoeitic Stem Cells(12, 13)  Bone Marrow and peripheral 
blood 
Multipotent All blood cell lineages, 
myocyte, hepatocyte, 
neural stem cell  
Neural Stem Cells(2)  Central nervous system Multipotent Neurons, astrocytes and 
oligodendrocytes 
Mammary Stem Cells(16)  Breast tissue Multipotent Myoepithelial cells, ductal 
epithelial cells, alveolar 
epithelial cells 
Intrahepatic(6, 17)  Liver Multipotent Hepatocytes, 
cholangiocytes and 
epithelial cells.  
Adipose(18)  Adipose Tissue Multipotent Adipocyte, osteocyte, 
chrondrocyte, neurone 
Limbal epithelial(19)  Eye (limpal crypts)  Unipotent Corneal epithelium 
Lung basal(6, 20)  
 
Lung Multipotent Mucosal cells, basal cells 
ciliated epithelial cells, 
pnemocytes  
Clara cells (20)       Lung Multipotent Clara cells, pnemocytes, 
mucous cells, ciliated 
epithelial cells, AEC I and 
II 
Mucous Cells (20)       Lung Multipotent Basal cell, mucous cells, 
ciliated epithelial cells 
Alveolar Epithelial Type II(20)       Lung Multipotent AEC I and II 
Gut epithelial(6)  Gut Multipotent Brush border enterocytes, 
paneth cells, goblet cells, 
enteroendocrine cells 
Keratinocyte(5, 7)  Basal layer of the epidermis, 
Base of the hair follice 
Multipotent Keratinocytes (both skin 
and hair) 
Oogonial(21)  Ovaries Unipotent Oocyte 
Spermatagonial(22)  Testes Unipotent Spermatozoa 
Satellite Cells(8, 23, 24)  Skeletal Muscle Multipotent  Myocytes, Adipocytes, 
Osteocytes 
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Cardiac(25)  Heart  Multipotent Cardiomyocytes, smooth 
muscle cells, endothelial 
cells 
 
STEM CELLS IN RESEARCH 
Efforts to understand the origins of specialised tissue 
cells, the role of stem cells in tissue homeostasis and 
more recently the role of stem cells in cancer have led 
to the development of sophisticated in vivo model 
systems and stem cell isolation techniques for ex vivo 
research. These vary in complexity depending on the 
stem cell type in question.  
   One of the most common and useful systems are 
those that provide information on stem cells function. 
In other words injection of putative stem cells into the 
relevant cleared organ results in recapitulation of that 
functional organ. Ex vivo mouse model examples of 
this are found for the bone marrow and mammary 
gland (20, 26). Mouse models have also been developed 
to study lung stem populations. The lung is a highly 
plastic organ, with >50% of epithelial linages 
exhibiting the stem characteristics of renewal and 
differentiation, but no single cell capable of 
differentiating into all lineages (refer to table 1) (20, 27). 
As such, mouse lung models often use lineage tracing 
methods, where cells progeny are marked. This in 
conjunction with lung injury, to promote proliferation, 
has been used to identify lung ‘stem’ populations (20).  
Linage tracing in conjunction with inducible transgenic 
mouse models have been used to study other stem 
population (28). This technique benefits from the ability 
to use it in a developing mouse, in comparison to the 
less valid cleared organ model.  
Another strategy is to examine endogenous cells or 
tissues either in single cell isolates or slices of paraffin 
embedded tissues, for stem cell markers. Frequently 
used stem cell markers include bromodeoxyuridine 
incorporation, Ki67, aldehyde dehyrodenase 
expression, CD49f, CD133 and CD34. These markers 
(and others) may also be used to estimate CSC 
frequencies in tumour biopsies (29-32). 
   Relative ease of access and depth of study has meant 
that hematopoietic stem cells are now very well 
characterised and can be purified relatively quickly 
using magnetic bead or fluorescent activated cell 
sorting (FACS) strategies. These strategies have been 
adapted for analysis and sorting of stem cells from 
other tissues, although there is much debate over the 
correct surface antigens to use as markers of stem and 
committed progenitors, particularly in the breast. As a 
result of these discrepancies, populations isolated for in 
vitro experimentation should be checked first for stem 
cell function using an in vivo model system such as 
described above. However in vitro models can be very 
informative as well allowing considerably higher 
throughput and lower costs than in vivo experiments. 
Many in vitro systems have been developed to mimic 
stem cell niche environments that enable these cells to 
be maintained in culture. These often employ spheroid 
culture in serum free, non-adherent culture conditions 
such as those developed by Dontu and co-workers for 
growth of mammary stem cells (16).  
 
STEM CELLS AND CANCER 
The importance of stem cells and their 
interrelationships with cancer stem cells (CSCs) in 
cancer initiation has been an important topic in recent 
years (33, 34). The long lifetime of a stem cell creates the 
potential for mutations to be acquired, including from 
ionising radiation (IR), which may lead to the transition 
into a CSC (35). In addition to this, dedifferentiation of 
cancer and cancer progenitor cells can produce CSCs 
(36, 37).  
   The existence of CSCs was inferred from the 
phenotypic heterogeneity observed within solid 
tumours (38). As solid tumours are thought to arise from 
a single cell, this suggests the cell-of-origin may have 
stem-like qualities. Further evidence came from 
comparing studies where human CSCs are able to form 
tumours in immunodeficient mice (30, 39, 40), but large 
numbers of non-stem like cancer cells are required for 
tumour formation (38).  
   CSCs have been highlighted as critical target 
populations in cancer therapy, including radiotherapy. 
Traditional cancer therapies may target the non-stem 
like bulk of a tumour but leave the small population of 
more resistant CSCs unaffected(41-43). Residual, 
treatment-resistant CSCs are the likely cause of tumour 
recurrence.  
 
RADIATION AND CANCER 
IR is a well-known carcinogen. Epidemiology studies 
have investigated the effects of population exposures 
such as the Japanese atomic bomb exposures and 
nuclear accidents. An increased risk of most types of 
solid cancer has been reported following these events 
(44, 45). Data from many of these studies supports the 
linear no-threshold model (LNT) (where risk of cancer 
is proportional to dose and there is no safe exposure 
range) (46, 47) although there have been reports of a 
saturation of response at high doses (44, 48). Important 
epidemiological data has also been revealed, for 
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example, the role of radioactive contaminated products 
(such as milk) inducing thyroid cancer in children (49).   
   Radiation doses can be divided into high (above 5 
Gy), moderate (between 0.5 and 5 Gy) and low doses 
(below 0.5 Gy) (50). Traditionally radiation was thought 
to cause carcinogenesis through direct DNA damage, in 
particular the formation of DNA double-strand breaks 
(DSB). However, other factors such as non-targeted 
effects (where direct DNA damage is not the main 
route) (51) such as bystander effects (the influence of 
irradiated cells on non-irradiated cells) (52) are also 
likely to affect carcinogenesis, especially at low doses 
(50). Research into these phenomena has shown for 
example low dose hypersensitivity, suggesting that the 
LNT model may not be applicable to low doses. 
 
RADIATION EFFECTS ON STEM CELLS 
A number of groups have attempted to understand the 
impact of IR directly on early events that may be 
precursors to carcinogenesis such as DNA damage; 
proliferation and cell death. The role of IR in 
transformation of stem cells into CSCs however, is not 
yet fully understood. Stem cells show modified 
responses to IR exposure in comparison to 
differentiated cells, possibly as they have modified 
DNA repair responses.  Tichy et al. (2010) found that 
murine ESCs favour the homologous recombination 
(HR) form of DSB repair, over non-homologous end 
joining (NHEJ) favoured murine embryonic fibroblasts 
(53). This is likely to be because HR is less error prone, 
as it requires a template for synthesis of the repaired 
DNA (53).  Despite this, murine ESCs exposed to high 
doses of IR (5 and 10 Gy) show up to a 100-fold 
increase in mutation rates (measured by loss of 
heterozygosity of Aprt gene) in comparison to adult 
fibroblasts, due to an increase in mitotic recombination 
(54). High doses of IR are known to decrease cell 
survival, although there are conflicting opinions on 
whether this is due to apoptosis.  Increased senescence 
(but not apoptosis) has been reported in murine 
haemopoietic stem cells (HSC) in vivo(55, 56) , while a 
study using human mesenchymal stem cells (MSCs) in 
vitro found 5 Gy γ-irradiation induced apoptosis(57) .  
   Both high and moderate doses appear to cause cell 
cycle arrest specifically at G2 rather than G1 (58, 59). 
Moderate doses also cause a wide variety of changes to 
the transcriptome. These include alterations in genes 
controlling cell cycle, cell death, transcription, cell 
morphology, molecular transport, amino acid 
metabolism, growth factors, and oxidative stress, in 
addition to cytokine, p53, TGF-β, and Wnt signalling 
(60-62). Studies of the effect of IR on stem cell 
differentiation has produced variable effects, with 
increased differentiation (61), decreased potency (63) or 
no effect observed (60).  There is also debate as to 
whether moderate doses induce transcription of 
apoptosis related genes, with Wilson et al. (2010) 
reporting an increase in ESCs (60) , while Rachidi et al. 
(2007) found a decrease in human epidermal cells(62) . 
Clonogenic experiments support a decrease in 
apoptosis, and indicate that stem cells are relatively 
radio-resistant in comparison to progenitor or 
differentiated cells (62, 64). Some inconsistencies may be 
due to differences in analysis time after irradiation. 
Sokolov et al. (2011) found that transcriptomes 
measured 2 hours after 1 Gy showed a pro-apoptotic 
response, while 16 hours after they showed an 
increased pro-survival response (65).  
   Low dose IR does not appear to cause an increase in 
cell death (60, 66), but increased proliferation has been 
observed in several studies.  Liang et al. (2011) found a 
significant increase in proliferation of rat MSC at 50 
and 75 mGy (67). However, increases in proliferation at 
20 mGy and 100 mGy failed to reach significance, 
indicating a non-linear response (67).  In vivo studies 
have also found increased proliferation, in both HSCs 
in (75 mGy) (68) and neural stem cells (NSC) (300 
mGy) (66). Bakinskis et al. (2011) found an increase in 
proliferation proteins in murine NSC, but no increase 
in proliferation rate (69). Wei et al. (2012) suggested 
that increased proliferation at low doses (300 mGy) 
was due to an increase in Wnt/β-catenin signalling, 
which was not seen at moderate (3Gy) doses (66). This 
contradicts Wilson et al. (2010) who found increased 
Wnt/β-catenin signalling in 2 Gy irradiated cells, but 
not in 400 mGy irradiated cells.  
 
STEM CELLS AND NON-TARGETED RADIATION 
EFFECTS 
Although there are discrepancies between the reports of 
Figure 2.  Model of radiation action on stem cells 
proposed by Shuryak et al(61).  Low LET IR is proposed 
to contribute to carcinogenesis by initiation of normal 
tissue stem cells to activated stem cells. Some of those 
may acquire further mutations and eventually become 
malignant. Conversely, the role of high LET IR is mainly 
through promotion of already activated stem cells via 
bystander signals produced by irradiated cells. 
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different groups, likely due to differences in the time of 
analysis post IR or model system used, an overview of 
low dose responses could be suggestive of a non-
targeted mechanism, both in vitro and in vivo. In most 
cases this seems to be a pro-survival affect. These 
effects have been shown in vivo for normal tissue as 
well as cancer model systems. Reports of a role of 
bystander effects on stem cells is also both tissue type 
and species dependent. Murine mesenchymal stem 
cells of the bone marrow do not display a bystander 
effect (70, 71) in contrast to HSCs of both mouse and 
human origin, in which bystander effects and genomic 
instability have been described (72-74) and in human 
NSCs, where radiation induced bystander signals 
induce differentiation (75). In the breast, an increase in 
the CSC population, compared to sham-irradiated mice, 
has been observed in Blab/c mice when the stroma was 
irradiated prior to inoculation of Trp 53 null epithelial 
cells. In these experiments an increase in tumour 
formation was also induced by low dose IR of the 
stroma, 100 % in 10 and 100 mGy-irradiated mice 
compared to 69 % in sham irradiated mice (76). 
Suggesting that factors secreted by the stroma activate 
stem cell self-renewal pathways. An increase in the 
stem cell population may create a larger target pool 
from which stem cells carrying mutations may arise. 
An in vitro investigation of bystander effects in normal 
HSCs employed a grid that allowed either 100% or 
50% of cells to be irradiated. These experiments 
showed that will shielding with the grid resulted in a 
decrease of cell killing, the frequency of chromosome 
aberrations was not affected by the grid with 1Gy 
irradiated cells having 0.135 aberrations per cells 
compared to 0.132 when 50% of cells were shielded by 
the grid(77) . 
 
STEM CELLS AND RADIATION 
CARCINOGENESIS 
A model describing the distinct roles of low and high 
LET radiation on stem cells has been proposed and 
tested in vivo using persistent dysplasia in mouse 
mammary glands as a positive outcome (78). Figure 2 is 
a schematic interpretation of that model. That research 
suggests that low LET IR directly initiates normal stem 
cells to an activated cell state, in which they are primed 
to acquire genetic mutations that ultimately lead to a 
malignant state. This results in a direct dose rate effect 
at low doses. In contrast, that group proposed that high 
LET IR contributes to carcinogenesis mainly through a 
bystander signalling mechanism. In that case a small 
number of cells are traversed by one or more tracks of 
densely IR, resulting in secretion of signal molecules 
that promote proliferation of nearby unirradiated stem 
cells that have been activated by an earlier event. The 
risk of carcinogenesis is then decreased as the dose rate 
increased due to a dominance of cell killing over 
bystander stimulated promotion.  
SUMMARY 
Stem cells are fundamental to normal embryonic 
development and tissue homeostasis. As such it is not 
surprising that studies of the DNA damage response of 
ESCs has shown a strong preference in these cells for 
the high fidelity form of DNA DSB repair, homologous 
recombination. This idea is supported by reports in 
some types of CSCs that they exhibit lower frequencies 
of DSBs compared to non-stem like cancer cells which 
is explained by increased ability to scavenge reactive 
oxygen species and slower DSB repair rate that favours 
repair by HR (79). Whether similar mechanisms exist in 
normal adult stem cells remains unclear and future 
research should be directed at understanding 
mechanisms that stem cells (other than HSCs) use to 
deal with mutagenic insults. As long-lived adult stem 
cells are relatively more quiescent they have been 
proposed to have an increased propensity to 
accumulate carcinogenic mutations. In recent years, so 
called cancer-stem cells have been observed and 
isolated in many types of human cancers including 
leukaemia and breast cancer. These cells are so named 
because they share many traits with normal stem cells 
most importantly the ability to self-renew. Several 
researchers have proposed normal adult stem and 
progenitor cells as the origin of CSCs.  
   The role of IR and non-targeted radiation effects in 
the activation of stem cells to a malignant state is 
unclear. However research in this area shows that 
whether a stem cell is sensitive or resistant to IR is 
highly dependent on the tissue of origin. Never the less 
several models of radiation carcinogenesis predict that 
stem cells play a major role in tumour initiation. In 
particular radiation induced bystander signals appear to 
promote proliferation and self-renewal. Future 
expansion of this area of research should define the 
mechanism(s) of action. Although in vitro and ex vivo 
studies are highly valuable it is clear that in depth in 
vivo analysis of the impact of IR on normal tissue stem 
cells is required to understand their role in 
carcinogenesis. 
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